Treatment of arthritic conditions, chronic inflammation or pain

Details for Australian Patent Application No. 2004281153 (hide)

Owner Pain Therapeutics, Inc.

Inventors Friedmann, Nadav; Schoenhard, Grant L.

Agent Shelston IP

Pub. Number AU-A-2004281153

PCT Pub. Number WO2005/037318

Priority 60/511,841 15.10.03 US; 60/566,189 27.04.04 US

Filing date 15 October 2004

Wipo publication date 28 April 2005

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/037318 Priority application(s): WO2005/037318

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281154-2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of Raf kinase for treatment of cancer

2004281152-Cystatin C as an antagonist of tgf-b and methods related thereto